Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mauricio René Garza-Herrera"'
Autor:
Maria Elena Romero-Ibarguengoitia, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Arnulfo González-Cantú, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Laura Patricia Montelongo-Cruz, Gerardo Francisco Del Rio-Parra, Mauricio René Garza-Herrera, Jessica Andrea Leal-Meléndez, Miguel Ángel Sanz-Sánchez
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0263942 (2022)
BackgroundVaccination is our main strategy to control SARS-CoV-2 infection. Given the decrease in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers three months after the second BNT162b2 dose, healthcare workers received a third booster six month
Externí odkaz:
https://doaj.org/article/75873610611640feb060c89e89af03f9
Autor:
Maria Elena Romero-Ibarguengoitia, Zulema Lourdes Flores-Salazar, Kimberly Dariela Arroyo-García, Rafael Soto-Gámez, Jessica Andrea Leal-Meléndez, Mauricio René Garza-Herrera, Gordon Bennett-Vidales, Mauricio Hurtado Cabrera, Roberto González-Habib, Liliann Peña Jiménez, Raúl Garza-Bulnes, Irene Antonieta Barco-Flores, Luis Fernando Castillo-Figueroa, Arnulfo Garza-Silva, Andrea Rivera-Cavazos, Diego Rivera-Salinas, Arnulfo González-Cantú, Miguel Ángel Sanz-Sánchez
Publikováno v:
Vaccines, Vol 11, Iss 2, p 415 (2023)
There is scarce information related to transplacental antibody transfer against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with different homologous and heterologous vaccination schemes. This study aimed to correlate the magnitude o
Externí odkaz:
https://doaj.org/article/9c4b7460bd8b4e6eb122e5324dad13e5
Autor:
Irene Antonieta Barco-Flores, Gerardo Francisco Del Rio-Parra, Maria Elena Romero-Ibarguengoitia, Mauricio René Garza-Herrera, Arnulfo González-Cantú, Diego Rivera-Salinas, Miguel Ángel Sanz-Sánchez, Rosalinda González-Facio, Laura Patricia Montelongo-Cruz, Jessica Andrea Leal-Meléndez, Ana Gabriela Armendariz-Vázquez, Yodira Guadalupe Hernández-Ruíz
BackgroundVaccination is our main strategy to control SARS-CoV-2 infection. Given a decrease in the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers three months following the second BNT162b2 dose, healthcare workers got a third booster dose aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a462579b68c76671caf08ba5bd2abfd
https://doi.org/10.1101/2021.10.20.21265269
https://doi.org/10.1101/2021.10.20.21265269
